ArticlePharmaceutics2020

Mesoporous Silica Nanoparticles as a Potential Platform for Vaccine Development against Tuberculosis.

Sandra Montalvo-Quirós et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.